6 Meridian’s Globus Medical GMED Stock Holding History

6 Meridian’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,175	Closed	-$246K	–	437
2021 Q2	$246K	Sell	3,175 -103	-3%	-$7.32K	0.02%	265
2021 Q1	$202K	Sell	3,278 -265	-7%	-$16.8K	0.02%	383
2020 Q4	$231K	Buy	+3,543	New	+$204K	0.02%	252
2020 Q3	–	Sell	-4,285	Closed	-$204K	–	315
2020 Q2	$204K	Sell	4,285 -7,275	-63%	-$351K	0.02%	298
2020 Q1	$492K	Buy	+11,560	New	+$571K	0.05%	255

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

6 Meridian's GMED Position: Q3 2021 in Review

6 Meridian sold out of Globus Medical (GMED) in Q3 2021, closing a stake of 3,175 shares — an estimated $246K sold.

6 Meridian first reported a position in GMED in Q1 2020 and held it in 5 quarters. The position peaked at $492K in Q1 2020. 388 funds tracked by Wall St. Rank hold GMED as of Q3 2021.

6 Meridian reported no remaining Globus Medical position as of Q3 2021 after selling out during the quarter.
6 Meridian sold 3,175 Globus Medical shares in Q3 2021, an estimated $246K.
6 Meridian first reported a position in Globus Medical in Q1 2020 and held it in 5 quarters.
6 Meridian's Globus Medical position peaked at $492K in Q1 2020.
388 funds tracked by Wall St. Rank held Globus Medical as of Q3 2021.

Based on 6 Meridian's 13F filing for Q3 2021, filed 3 Nov 2021.